— Know what they know.
Not Investment Advice

ROTH OTC

PharmaRoth Labs, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -90.0% 1Y: -90.0% 3Y: -99.8% 5Y: -99.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 48 · $3512 mcap · 287M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$304K +47.1% ▲
Total Liabilities
$863K +23.4% ▲
5Y CAGR: +24.2%
Shareholders Equity
-$549K -13.8% ▼
Cash & Investments
$1K +52.4% ▲
Total Debt
$250K +0.0% ▲
5Y CAGR: +0.0%
Net Debt
$249K -0.2% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2013FY2014FY2015FY2016FY2017
— Assets —
Cash$623$6K$824$762$1K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$623$6K$824$762$1K
Net Receivables$95K$172K$78K$30K$83K
Inventory$14K$35K$45K$102K$150K
Other Current Assets$0$0$153$0$0
Total Current Assets$160K$291K$209K$207K$304K
Property, Plant & Equip.$670$0$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$670$0$0$0$0
Total Assets$161K$291K$209K$207K$304K
— Liabilities —
Accounts Payable$91K$40K$52K$38K$118K
Short-Term Debt$0$0$0$250K$250K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$455K$541K$625K$412K$495K
Total Current Liabilities$595K$650K$678K$700K$863K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$595K$650K$678K$700K$863K
— Equity —
Common Stock$248K$309K$349K$379K$391K
Retained Earnings-$2M-$2M-$3M-$3M-$3M
Accumulated OCI$166-$146$6K$10K$10K
Total Stockholders Equity-$431K-$358K-$459K-$483K-$549K
Total Liabilities & Equity$161K$291K$209K$207K$304K
— Key Metrics —
Total Debt$0$0$0$250K$250K
Net Debt-$623-$6K-$824$249K$249K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms